La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Cimpress a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Cimpress..

Cimpress (NASDAQ:CMPR) Azioni, Catena delle Opzioni

Cimpress

Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.

Cimpress PLC

GENTERA SAB DE CV ORD by Gentera Sab De CV

Gentera SAB de CV

COMPARTAMOS SAB DE CV ADR by Gentera Sab De CV

Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Buy and lowers the price target from $120 to $110.

News

Price Target

Analyst Ratings

CMPR

Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $110

WIIM

Cimpress shares are trading lower after the company reported worse-than-expected Q1 EPS results.

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $0.29 by 272.41 percent. This is a 394.12 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $804.97 million which beat the analyst consensus estimate of $798.92 million by 0.76 percent. This is a 6.30 percent increase over sales of $757.29 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Cimpress Q1 EPS $(0.50) Misses $0.29 Estimate, Sales $804.97M Beat $798.92M Estimate

<ul>
<li>Global leader in print mass customization, known for its groundbreaking innovations, teams with Kornit to set new industry standards</li>
<li>OGAT redefines traditional mass production models with cutting-edge technology, combining Kornit's digital direct-to-fabric pigment printing with a comprehensive on-demand production workflow &nbsp;</li>
<li>The future of fashion is here – limitless creativity, finished garments within days, no minimum orders, increased profitability through the elimination of unsold inventory, all within a sustainable production model &nbsp;</li>
</ul>
LAS VEGAS, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PRINTING UNITED EXPO--<a href="https://www.globenewswire.com/Tracker?data=M6QhrfWFZhtY_9_nBPAqLyL9oaH7vISsEH9HPmTERmvu7wFiO0JetRQKhp4w5NnsQsStz36K3PM9PoNzbuFOWn3iF_ezqyFYznRtq0qC5SQ=">Kornit Digital LTD.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRNT#NASDAQ">KRNT</a>) ("Kornit" or the "Company"), a worldwide market leader in sustainable, on-demand digital fashion and textile production technologies, announced today the Company is teaming with fashion pioneer OGAT - One Garment at a Time, a new brand launched by Pixartprinting, part of Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>), to power the future of fashion - today. The brand embraces Kornit's award-winning direct-to-fabric technology alongside advanced product creation and logistics workflows, to set new standards for fashion, challenging outdated production models with innovative on-demand solutions.

KRNT

OGAT And Kornit Digital Team Up In Fashion Production With On-Demand, Sustainable Technology

Cimpress Plc shares are trading higher after Barrington Research maintained an Outperform rating on the stock and raised its price target from $113 to $119.

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Outperform and raises the price target from $113 to $119.

Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $119

ALTG

ARIS

ARRY

ASLE

ATKR

AXON

CAAP

CAPT

CARR

CDLR

CHRW

CNTM

DRVN

Embraer-Empresa Brasileira De Aeronautica

EVEX

EXPD

FLNC

FTAI

FWRD

GWAV

HUBB

HYLN

HYZN

JOBY

LICN

MYRG

NCNC

NKLA

NVRI

PRIM

REZI

ROCK

RUSHA

RUSHB

SHLS

STAF

TFII

TOMZ

TPIC

ULCC

WLFC

XPON

Shares of companies within the broader industrial sector are trading lower amid overall market weakness following weak US data.

Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Buy and raises the price target from $110 to $120.

Truist Securities Maintains Buy on Cimpress, Raises Price Target to $120

Cimpress shares are trading higher after the company reported better-than-expected Q4 revenue results.

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) reported quarterly sales of $832.61 million which beat the analyst consensus estimate of $832.55 million by 0.01 percent. This is a 5.55 percent increase over sales of $788.85 million the same period last year.

Cimpress Q4 Sales $832.61M Beat $832.55M Estimate

Comcast (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmcsa#NASDAQ">CMCSA</a>) reported second-quarter 2024 adjusted earnings of $1.21 per share, which beat the Zacks Consensus Estimate by 9.01% and increased 7.1% year over year.
Consolidated revenues decreased 2.7% year over year to $29.6 billion and missed the Zacks Consensus Estimate by 1.26%.
Domestic broadband average rate per customer increased 3.6% and drove domestic broadband revenue growth of 3% to $6.6 billion in the second quarter.&nbsp;
Comcast lost 120K domestic broadband customers in the reported quarter. Moreover, it lost 419K video customers. Domestic wireless customer lines increased 20% compared with the year-ago quarter to 7.2 million, including net additions of 322K in the second quarter.
Shares of CMCSA have lost 9.9% year to date compared with the Zacks Consumer Discretionary sector&#39;s decline of 1.3%.
<div class="chart_embed">
<h3>Comcast Corporation Price, Consensus and EPS Surprise</h3>
<img alt="Comcast Corporation Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/1d/1721741869.png" style="height:285px; width:620px" title="" />
Comcast Corporation price-consensus-eps-surprise-chart | Comcast Corporation Quote
</div>
<h3>Quarter Details</h3>
Connectivity &amp; Platforms revenues (68.2% of revenues) decreased 0.6% year over year to $20.24 billion in the reported quarter.
Residential Connectivity &amp; Platforms revenues declined 1.4% year over year at $17.82 billion. Business Services Connectivity revenues increased 5.6% year over year to $2.42 billion.
Content &amp; Experiences revenues (33.9% of revenues) decreased 7.5% year over year to $10.05 billion. Media revenues rose 2.1% year over year to $6.32 billion, primarily due to higher domestic distribution revenues. Peacock&#39;s paid subscribers rallied nearly 38% year over year to 33 million. Peacock&#39;s revenues in the second quarter jumped 28% to $1 billion.
Studios decreased 27% year over year to $2.25 billion, primarily due to lower theatrical revenues and content licensing revenues. Theatrical revenues decreased due to higher revenues from the volume and strength of theatrical releases in the prior-year period, including The Super Mario Bros. Movie and Fast X. Content licensing revenues fell primarily due to the timing of when content was made available by television studios.
Theme Parks lost 10.6% year over year to $1.97 billion due to lower revenues at the company&#39;s domestic theme parks, attributable to lower guest attendance, as well as the negative impact of foreign currency at international theme parks.
<h3>Operating Details</h3>
Costs and expenses in the second quarter of 2024 decreased 3.2% year over year to $23.05 billion.
Programming &amp; production costs decreased 10% from the year-ago quarter to $7.96 billion. Marketing and promotional expenses decreased 8.5% year over year to $1.92 billion.
Adjusted EBITDA decreased 0.7% from the year-ago quarter to $10.17 billion.&nbsp;
Total Connectivity &amp; Platforms adjusted EBITDA gained 1.6% year over year to $8.48 billion.&nbsp; 
Content &amp; Experiences adjusted EBITDA was $1.94 billion, down 10.9% year over year.
<h3>Cash Flow &amp; Liquidity</h3>
As of Jun 30, 2024, cash and cash equivalents were $6.06 billion, which increased from $6.58 billion as of Mar 31, 2024.
As of Jun 30, 2024, consolidated total debt was $98.1 billion compared with $96.5 billion as of Mar 31, 2024.
In the second quarter of 2024, Comcast generated $4.72 billion in cash from operations, which decreased from $7.84 billion reported in the previous quarter. Free cash flow was $1.33 billion in the reported quarter, which decreased from $4.53 billion reported in the previous quarter.
CMCSA paid dividends totaling $1.2 billion and repurchased 56.4 million of its shares for $2.2 billion, resulting in a total return of capital to shareholders of $3.4 billion.
<h3>Zacks Rank &amp; Stocks to Consider</h3>
Currently, Comcast carries a Zacks Rank #3 (Hold).
Cinemark (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cnk#NYSE">CNK</a>), Cimpress (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmpr#NASDAQ">CMPR</a>) and Roblox (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rblx#NYSE">RBLX</a>) are some better-ranked stocks that investors can consider in the broader sector. DIS, REYN and RBLX carry a Zacks Rank #2 (Buy) each at present.
Shares of Cinemark have jumped 54% year to date. CNK is set to report second-quarter 2024 results on Aug 2.
Shares of Cimpress have gained 15.5% year to date. CMPR is slated to report first-quarter 2024 results on Jul 31.
Shares of Roblox have plunged 10.3% year to date. RBLX is set to report second-quarter 2024 results on Aug 1.
<a href="https://www.zacks.com/stock/news/2307211/comcast-cmcsa-q2-earnings-beat-estimates-revenues-miss?cid=CS-BENZ-FT-analyst_blog|earnings_article-2307211">To read this article on Zacks.com click here.</a>

Entertainment

Dividends

Markets

Trading Ideas

General

CMCSA

RBLX

Comcast Q2 Earnings Beat Estimates, Revenues Miss

ACHR

ACVA

CHPT

DXPE

FBIN

GTEC

HEES

ILAG

JELD

Citigroup Financial 300% Minupon Princ Protected Nts for Russell 2000 Index

SHYF

SITE

SKYX

SMXT

SNTG

TRNS

XMTR

Shares of companies within the broader industrial sector are trading higher following Core Retail Sales and Retail Sales economic data. Also, strength may be due to trader optimism that the Fed will cut rates.

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Outperform and maintains $113 price target.

Barrington Research Maintains Outperform on Cimpress, Maintains $113 Price Target

Cimpress shares are trading lower after the company reported worse-than-expected Q3 sales results.

Cimpress Q3 2024 Adj EPS $(0.15) May Not Compare To $0.14 Estimate, Sales $780.59M Miss $782.85M Estimate

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Outperform and raises the price target from $100 to $113.

Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Buy and raises the price target from $90 to $110.

Truist Securities Maintains Buy on Cimpress, Raises Price Target to $110-Report Released on 1 February 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday.
The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&amp;P 500 also rose, gaining, 0.87% to 4,887.70.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/36883775/320m-bet-on-this-healthcare-stock-check-out-these-3-stocks-insiders-are-buying"> $320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Consumer staples shares rose by 1.6% on Thursday.
In trading on Thursday, energy shares fell by 0.2%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Honeywell International Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hon#NASDAQ">HON</a>) reported downbeat revenue for its fourth quarter and issued weak outlook.
Honeywell reported fourth-quarter fiscal 2023 sales of $9.44 billion, up 3% year-over-year on a reported basis and +2% on an organic basis, missing the consensus of $9.70 billion. Adjusted EPS was $2.60 (+3% Y/Y), beating the consensus of $2.59.
For the first quarter, Honeywell sees adjusted EPS of $2.12-$2.22 (consensus $2.24) and sales of $8.9 billion-$9.2 billion (consensus $9.248 billion).
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Cimpress plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmpr#NASDAQ">CMPR</a>) shares shot up 23% to $92.54 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.
Shares of NeuroBo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrbo#NASDAQ">NRBO</a>) got a boost, surging 72% to $5.61 after the company announced FDA clearance of the IND for a Phase 1 clinical trial of DA-1726 for the treatment of obesity.
Celularity Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celu#NASDAQ">CELU</a>) shares were also up, gaining 28% to $0.4854. Celularity said it sees FY24 net sales of $50 million to $56 million.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) shares dropped 61% to $3.40 after the company announced pricing of $6.2 million public offering.
Shares of Peloton Interactive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) were down 23% to $4.2711 after the company reported mixed second-quarter financial results and issued third-quarter revenue guidance below estimates.
Volcon, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) was down, falling 23% to $0.1031 after the company announced a 1-for-45 reverse stock split.
Also Check This Out:<a href="https://www.benzinga.com/news/24/02/36886194/at-t-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday"> AT&amp;T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 1.5% to $74.69 while gold traded up 0.3% at $2,074.30.
Silver traded up 0.3% to $23.23 on Thursday while copper fell 1.4% to $3.8520.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were lower today. The eurozone&rsquo;s STOXX 600 fell 0.37%, London&rsquo;s FTSE 100 fell 0.11% while Spain&rsquo;s IBEX 35 Index fell 0.63% The German DAX fell 0.26% French CAC 40 fell 0.89% while Italy&rsquo;s FTSE MIB Index fell 0.18%.
The inflation rate in the Eurozone fell to 2.8% year-over-year in January from 2.9% in the prior month. The HCOB Eurozone manufacturing PMI climbed to 46.6 in January, recording the highest level in ten months.
The S&amp;P Global UK manufacturing PMI fell to 47 in January versus the preliminary reading of 47.3, while German manufacturing PMI rose to 45.5 in January from 43.3 in December. The HCOB France manufacturing PMI climbed to 43.1 in January from 42.1 in the prior month.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Thursday, with Japan&rsquo;s Nikkei 225 falling 0.76%, Hong Kong&rsquo;s Hang Seng Index gaining 0.52% and China&rsquo;s Shanghai Composite Index falling 0.64%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell 0.14%.
The Hong Kong Monetary Authority maintained its base rate at 5.75%. Retail sales in Hong Kong rose 4.8% year-over-year in December compared to a revised 12.4% surge in the earlier month. The au Jibun Bank Japan manufacturing PMI edged higher to 48.0 in January from 47.9 in December.
The HSBC India manufacturing PMI fell to 56.5 in January versus a flash reading of 56.9. The Caixin China general manufacturing PMI came in unchanged at 50.8 in January.
&nbsp;
<h3>Economics</h3>
&nbsp;
Nonfarm business sector labor productivity rose by 3.2% in the fourth quarter compared to a revised 4.9% increase in the third quarter.
Unit labor costs rose an annualized 0.5% in the fourth quarter versus a revised 1.1% decline in the prior period.
U.S. initial jobless claims increased to 224,000 in the week ended January 27, versus a revised 215,000 in the prior week and compared to market estimates of 212,000.
The S&amp;P Global US manufacturing PMI rose to 50.7 in January versus a preliminary reading of 50.3.
Construction spending rose by 0.9% month-over-month to an annual rate of $2,096 billion in December.
The ISM manufacturing PMI rose to 49.1 in January, notching the highest level since Oct. 2022, compared to 47.1 in December, and topping market estimates of 47.
Now Read This: <a href="https://www.benzinga.com/news/24/02/36886117/fastly-general-mills-and-2-other-stocks-insiders-are-selling"> Fastly, General Mills And 2 Other Stocks Insiders Are Selling </a>

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

CELU

NRBO

PTON

REVB

VLCN

Dow Jumps 250 Points; Honeywell Issues Weak Forecast

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chrw#NASDAQ">CHRW</a>) fell sharply during Thursday&rsquo;s session after the company reported worse-than-expected fourth-quarter financial results.
C.H. Robinson Worldwide posted adjusted earnings of 50 cents per share, missing market estimates if 81 cents per share. The company&rsquo;s quarterly sales came in at $4.20 billion versus estimates of $4.34 billion.
C.H. Robinson Worldwide shares dipped 12.6% to $73.49 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) shares climbed 57.3% to $6.45. David E. Lazar recently disclosed a 51% active stake in Minim.</li>
<li>Clearmind Medicine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmnd#NASDAQ">CMND</a>) jumped 51% to $2.17. Clearmind Medicine announced long-term licensing agreement with BIRAD.</li>
<li>NeuroBo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrbo#NASDAQ">NRBO</a>) climbed 52.9% to $5.00. NeuroBo Pharmaceuticals announced FDA clearance of IND for Phase 1 clinical trial of DA-1726 for the treatment of obesity.</li>
<li>FibroBiologics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fblg#NASDAQ">FBLG</a>) shares climbed 47.4% to $42.90. FibroBiologics announced direct listing on the NASDAQ.</li>
<li>Celularity Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celu#NASDAQ">CELU</a>) rose 36% to $0.5191. Celularity said it sees FY24 net sales of $50 million to $56 million.</li>
<li>Cimpress plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmpr#NASDAQ">CMPR</a>) jumped 28.8% to $96.90 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.</li>
<li>TuSimple Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsp#NASDAQ">TSP</a>) rose 28% to $0.2950.</li>
<li>Elevai Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elab#NASDAQ">ELAB</a>) gained 23.5% to $0.84 after gaining 8% on Wednesday.</li>
<li>Asset Entities Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asst#NASDAQ">ASST</a>) climbed 22.8% to $0.5650.</li>
<li>Kiora Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kprx#NASDAQ">KPRX</a>) shares jumped 20.4% to $0.6649. Kiora Pharmaceuticals announced a private placement of up to $45 million.</li>
<li>Evaxion Biotech A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evax#NASDAQ">EVAX</a>) gained 19.5% to $4.70. Evaxion Biotech announced pricing of $15 million public offering of 3.750 million ADS at $4.00 per ADS.</li>
<li>Nextracker Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxt#NASDAQ">NXT</a>) rose climbed 18.8% to $53.79 after the company reported better-than-expected third-quarter financial results.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) jumped 18.1% to $3.5791.</li>
<li>BioRestorative Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brtx#NASDAQ">BRTX</a>) gained 16.4% to $1.8850.</li>
<li>Corteva, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctva#NYSE">CTVA</a>) gained 16.2% to $52.84 after the company reported better-than-expected quarterly financial results, issued 2024 guidance and announced a $1 billion repurchase plan.</li>
<li>Nextracker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxt#NYSE">NXT</a>) jumped 16.1% to $52.56 after the company reported better-than-expected quarterly financial results.</li>
<li>Yoshiharu Global Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yosh#NASDAQ">YOSH</a>) rose 15.9% to $5.10.</li>
<li>FuelCell Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fcel#NASDAQ">FCEL</a>) gained 15.7% to $1.3885.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) climbed 12.2% to $4.9900. Plug Power said it completed first customer fill of liquid green hydrogen at its Georgia plant.</li>
<li>Credit Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cacc#NASDAQ">CACC</a>) jumped 11.9% to $605.43 following upbeat earnings.</li>
<li>Digi International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dgii#NASDAQ">DGII</a>) gained 11.7% to $27.17 following strong results.</li>
<li>Oragenics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ogen#NYSE">OGEN</a>) gained 11.1% to $2.5561 after dipping around 34% on Wednesday. Oragenics recently announced termination of at-market offering program.</li>
<li>Allegro MicroSystems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/algm#NASDAQ">ALGM</a>) climbed 10.9% to $28.77 following upbeat earnings.</li>
<li>Ferrari N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/race#NYSE">RACE</a>) gained 10.4% to $382.17 after the company reported fourth-quarter financial results and issued 2024 guidance.</li>
<li>Etsy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etsy#NASDAQ">ETSY</a>) rose 9.6% to $72.95 after the company announced the appointment of Elliott Investment Management&rsquo;s Marc Steinberg to its board.</li>
<li>Boot Barn Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boot#NYSE">BOOT</a>) gained 8.4% to $77.79 following upbeat earnings.</li>
<li>Sally Beauty Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbh#NYSE">SBH</a>) jumped 7.4% to $13.24 following upbeat earnings.</li>
<li>EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) gained 7.2% to $13.53.</li>
<li>Deutsche Bank Aktiengesellschaft (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) shares gained 6.2% to $13.65 after the company posted fourth-quarter results and announced plans to cut 3,500 jobs. Deutsche Bank plans to increase both share repurchases and dividends by at least 50% year-over-year in 2024.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) shares dipped 61.1% to $3.4268 after the company announced pricing of $6.2 million public offering.</li>
<li>InVivo Therapeutics Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nviv#NASDAQ">NVIV</a>) fell 49% to $0.3267. InVivo Therapeutics Holdings and subsidiary filed for Chapter 11 bankruptcy in Delaware but plan to continue operating under court supervision as a debtor-in-possession.</li>
<li>Hesai Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsai#NASDAQ">HSAI</a>) declined 28.2% to $4.1817. Hesai Group issued a statement on the U.S. Department of Defense &quot;Chinese Military Companies&quot; list.</li>
<li>FibroBiologics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fblg#NASDAQ">FBLG</a>) fell 27.4% to $21.12.</li>
<li>Volcon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) shares dipped 24.3% to $0.1020 after the company announced a 1-for-45 reverse stock split.</li>
<li>Peloton Interactive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) fell 22.9% to $4.2850 after the company reported mixed second-quarter financial results and issued third-quarter revenue guidance below estimates.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) fell 21.4% to $8.10.</li>
<li>ADDvantage Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aey#NASDAQ">AEY</a>) shares declined 21.3% to $1.4320.</li>
<li>Earlyworks Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elws#NASDAQ">ELWS</a>) fell 21.2% to $0.44 after surging more than 55% on Wednesday.</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) shares declined 20.6% to $1.0799 after surging over 115% on Wednesday.</li>
<li>Alaunos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) fell 19.3% to $2.0410.</li>
<li>Rocket Lab USA, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rklb#NASDAQ">RKLB</a>) shares declined 18.7% to $3.9450 after the company announced a proposed offering of $275 million convertible senior notes.</li>
<li>Bullfrog AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfrg#NASDAQ">BFRG</a>) fell 18.4% to $3.9736 after declining 9% on Wednesday. Bullfrog AI Holdings recently filed shelf offering of 786,938 shares and accompanying warrants at $6.63 per share and accompanying warrant.</li>
<li>Thermon Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/thr#NYSE">THR</a>) fell 16.2% to $27.45 following third-quarter results.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) declined 15.9% to $1.8250 after Volvo Cars said it will no longer provide further funding to the company.</li>
<li>Surmodics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srdx#NASDAQ">SRDX</a>) fell 14.9% to $29.97 following first-quarter results.</li>
<li>MaxLinear, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mxl#NYSE">MXL</a>) shares dipped 14.4% to $17.83 after reporting fourth-quarter results.</li>
<li>8x8, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eght#NASDAQ">EGHT</a>) fell 13.5% to $2.9050 following weak sales.</li>
<li>New York Community Bancorp, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NYSE">NYCB</a>) dipped 13.5% to $5.60 after multiple firms downgraded the stock following the company&#39;s fourth-quarter results.</li>
<li>IHS Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ihs#NYSE">IHS</a>) fell 11.9% to $3.5050.</li>
<li>Western Alliance Bancorporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wal#NYSE">WAL</a>) dipped 10% to $57.58.</li>
<li>Aflac Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/afl#NYSE">AFL</a>) shares declined 9.7% to $76.17 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Markel Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkl#NYSE">MKL</a>) dipped 9.4% to $1,356.53 after the company reported 2023 financial results.</li>
<li>Wolfspeed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wolf#NYSE">WOLF</a>) shares fell 9.2% to $29.56 following the company&#39;s second-quarter earnings.</li>
<li>Valley National Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vly#NASDAQ">VLY</a>) dipped 8% to $8.85.</li>
<li>Zions Bancorporation, National Association (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zion#NASDAQ">ZION</a>) fell 6.6% to $39.12.</li>
<li>ING Groep N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ing#NYSE">ING</a>) shares declined 5.9% to $13.37 following fourth-quarter results.</li>
<li>Sanofi (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sny#NASDAQ">SNY</a>) fell 3.2% to $48.33 after the company posted fourth-quarter results and named Fran&ccedil;ois-Xavier Roger as Chief Financial Officer.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/36889477/bitcoin-falls-following-jobless-claims-data-jupiter-ftx-token-among-top-losers"> Bitcoin Falls Following Jobless Claims Data; Jupiter, FTX Token Among Top Losers</a>

Movers

ALGM

ASST

BFRG

BOOT

BRTX

CACC

CMAX

CMND

CTVA

DGII

EGHT

ELAB

ELWS

ETSY

EVAX

EVER

FBLG

FCEL

HSAI

IFBD

Kiora Pharmaceuticals, Inc. - Common Stock

KPRX

MINM

NVIV

NYCB

OGEN

PLUG

PSNY

RACE

RKLB

SPWR

SRDX

TCRT

WOLF

YOSH

ZION

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Analyst Kevin Steinke of Barrington reiterated a Buy rating on Cimpress (CMPR – Research Report), with a price target of $119.00. Kevin Steinke has...

Strong Q4 Performance and Positive Outlook Justify Buy Rating for Cimpress

AeroVironment soars to top industrial gainer of week, while Symbotic leads decliners

Catalyst Watch: Apple's iPhone event, Oracle earnings, Google antitrust trial, and the August CPI print

In a report released today, Youssef Squali from Truist Financial reiterated a Buy rating on Cimpress (CMPR – Research Report). The company's shares...

Truist Financial Remains a Buy on Cimpress (CMPR)

Cimpress ( ($CMPR) ) just unveiled an update. Cimpress plc has announced a private offering of $525 million senior notes due 2032, alongside plans ...

Cimpress Announces Senior Notes Offering and Credit Facility Revamp

Cimpress prices senior notes offering of $525M

Rocket Lab soars to top industrial gainer of week, Rentokil drops after profit warning

Cimpress Steadies Ship With A Recovery In Sight (Rating Upgrade)

In a report released today, Youssef Squali from Truist Financial maintained a Buy rating on Cimpress (CMPR – Research Report). The company's shares...

Cimpress (CMPR) Receives a Buy from Truist Financial

Cimpress GAAP EPS of -$0.50 misses by $0.79, revenue of $804.97M beats by $6.05M

Comments

Cimpress

Cimpress (CMPR) Opzioni

Cimpress (NASDAQ:CMPR) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO